Scarica l'app Stockscreener
31.85
0.19%
0.06
Pre-mercato:
33.00
1.15
+3.61%
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
MBX Technical Analysis | Trend, Signals & Chart Patterns | MBX BIOSCIENCES INC (NASDAQ:MBX) - ChartMill
MBX Biosciences, Inc. thanks clinical trial participants as new therapies progress - Traders Union
MBX Biosciences (MBX) price target increased by 11.23% to 69.55 - MSN
LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $91 - Moomoo
Insider Stock Buying Reaches US$1.06m On MBX Biosciences - Yahoo Finance
MBX Biosciences Advances Obesity And PBH Pipeline As Shares Surge - Sahm
Insider sale notice: 15,000 shares planned | MBX SEC FilingForm 144 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT) and MBX Biosciences, Inc. (MBX) - The Globe and Mail
MBX Biosciences (NASDAQ:MBX) Trading Down 8.8%Here's What Happened - MarketBeat
A Quick Look at Today's Ratings for MBX Biosciences(MBX.US), With a Forecast Between $56 to $86 - Moomoo
AstraZeneca's Rare Disease Drug Shows Reduced Dependence On Calcium Supplements - Benzinga
MBX Biosciences (NASDAQ:MBX) Price Target Raised to $86.00 at Citizens Jmp - MarketBeat
Q2 EPS Estimates for MBX Biosciences Boosted by Analyst - MarketBeat
Citizens raises MBX Biosciences stock price target on obesity drug data By Investing.com - Investing.com South Africa
Citizens raises MBX Biosciences stock price target on obesity drug data - Investing.com Nigeria
MBX Biosciences stock hits all-time high at 44.98 USD By Investing.com - Investing.com India
MBX Biosciences reports early obesity drug trial data By Investing.com - Investing.com Australia
Stifel raises MBX Biosciences stock price target to $56 on obesity data - Investing.com UK
MBX Biosciences, Inc. (MBX) Discusses Novel Approaches and Clinical Progress in Obesity Therapeutics PortfolioSlideshow (NASDAQ:MBX) 2026-05-11 - Seeking Alpha
Stifel raises MBX Biosciences stock price target to $56 on obesity data By Investing.com - Investing.com South Africa
MBX highlights early data for monthly obesity drug MBX-4291 - BioWorld News
Mbx Biosciences Insider Sold Shares Worth $2,685,515, According to a Recent SEC Filing - marketscreener.com
MBX Biosciences (MBX) CMO exercises options and sells 70,003 shares under 10b5-1 plan - Stock Titan
MBX (NASDAQ) affiliate sells multiple tranches of shares in Rule 144 notices - Stock Titan
MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push - MarketBeat
MBX: MBX 4291 achieves 7% mean weight loss with strong tolerability in phase I, supporting monthly dosing - TradingView
Insiders Of MBX Biosciences Are Up 125% On Their US$1.06m Purchase - Moomoo
MBX Biosciences (NASDAQ:MBX) Price Target Raised to $70.00 - MarketBeat
MBX Biosciences Reports Positive Phase 1 Results for Once-Monthly Obesity Drug MBX 4291 and Expands Obesity Pipeline - Minichart
MBX: MBX's obesity pipeline advances with promising once-monthly candidates and strong financial runway - TradingView
MBX Biosciences : May 2026 Obesity Day Presentation – Final - marketscreener.com
MBX Biosciences stock hits all-time high at 44.98 USD - Investing.com
Obesity portfolio update features new clinical data from MBX Biosciences, Inc. - Traders Union
MBX Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Truist Raises Price Target on MBX Biosciences to $70 From $50, Keeps Buy Rating - marketscreener.com
MBX Biosciences Highlights Positive Phase 1 Obesity Data - TipRanks
MBX Biosciences reports early obesity drug trial data - Investing.com
MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing - The Manila Times
MBX Biosciences, Inc. Provides Obesity Portfolio Update Including Initial Phase 1 Data For MBX 4291 Supporting Potential For Once-Monthly Dosing - marketscreener.com
Brokers Set Expectations for MBX Biosciences Q1 Earnings - MarketBeat
A Look At MBX Biosciences (MBX) Valuation After Its Recent Share Price Momentum - Sahm
Wall Street Zen Upgrades MBX Biosciences (NASDAQ:MBX) to Hold - MarketBeat
MBX SEC FilingsMBX Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Top MBX Biosciences Executive Makes Notable Stock Move - TipRanks
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):